Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (6): 26-34.doi: 10.6040/j.issn.1671-7554.0.2021.0110
Previous Articles Next Articles
WANG Jing1,2, XIE Yan1,2, LI Peilong1,2, DU Lutao1,2, WANG Chuanxin1,2
CLC Number:
| [1] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 Cancers in 185 Countries [J]. CA Cancer J Clin, 2021, 71(3): 209-249. [2] Sun W, Yan L. Gastric cancer: current and evolving treatment landscape [J]. Chin J Cancer, 2016, 35(1): 83. doi: 10.1186/s40880-016-0147-6. [3] Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132. [4] Van Cutsem E, Sagaert X, Topal B, et al. Gastric cancer [J]. Lancet, 2016, 388(10060): 2654-2664. [5] Panarese I, De Vita F, Ronchi A, et al. Predictive biomarkers along gastric cancer pathogenetic pathways [J]. Expert Rev Anticancer Ther, 2017, 17(5): 417-425. [6] Vedeld HM, Goel A, Lind GE. Epigenetic biomarkers in gastrointestinal cancers: the current state and clinical perspectives [J]. Semin Cancer Biol, 2018, 51: 36-49. doi: 10.1016/j.semcancer.2017.12.004. [7] Esteller M. Epigenetics in cancer [J]. N Engl J Med, 2008, 358(11): 1148-1159. [8] Ren J, Lu P, Zhou X, et al. Genome-scale methylation analysis of circulating cell-Free DNA in gastric cancer patients [J]. Clin Chem, 2022, 68(2): 354-364. [9] Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer [J]. Epigenomics, 2015, 7(3): 475-486. [10] Zhang Y, Petropoulos S, Liu J, et al. The signature of liver cancer in immune cells DNA methylation [J]. Clin Epigenetics, 2018, 10: 8. doi: 10.1186/s13148-017-0436-1. [11] Klumper N, Ralser DJ, Bawden EG, et al. LAG3(LAG-3, CD223)DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma [J]. J Immunother Cancer, 2020, 8(1): e000552. doi: 10.1136/jitc-2020-000552. [12] Velotti F, Barchetta I, Cimini FA, et al. Granzyme B in inflammatory diseases: apoptosis, inflammation, extracellular matrix remodeling, epithelial-to-mesenchymal transition and fibrosis [J]. Front Immunol, 2020, 11: 587581. doi: 10.3389/fimmu.2020.587581. [13] Turner CT, Lim D, Granville DJ. Granzyme B in skin inflammation and disease [J]. Matrix Biol, 2019, 75-76: 126-140. doi: 10.1016/j.matbio.2017.12.005. [14] Jeong KH, Kim SK, Seo JK, et al. Association of GZMB polymorphisms and susceptibility to non-segmental vitiligo in a Korean population [J]. Sci Rep, 2021, 11(1): 397. doi: 10.1038/s41598-020-79705-0. [15] Hiroyasu S, Zeglinski MR, Zhao H, et al. Granzyme B inhibition reduces disease severity in autoimmune blistering diseases [J]. Nat Commun, 2021, 12(1): 302. doi: 10.1038/s41467-020-20604-3. [16] Zhang Z, Zhang Y, Xia S, et al. Gasdermin E suppresses tumour growth by activating anti-tumour immunity [J]. Nature, 2020, 579(7799): 415-420. [17] Yao K, Uedo N, Kamada T, et al. Guidelines for endoscopic diagnosis of early gastric cancer [J]. Dig Endosc, 2020, 32(5): 663-698. [18] 管鑫, 李俊垚, 王明慧, 等. 胃镜在健康体检人群胃早癌及癌前疾病筛查中的临床意义[J]. 中国内镜杂志, 2019, 25(7): 34-41. GUAN Xin, LI Junyao, WANG Minghui, et al. Clinical significance of gastroscope in healthy population screening of early gastric cancer and precancerous diseases [J]. China Journal of Endoscopy, 2019, 25(7): 34-41. [19] Luo D, Yang Q, Wang H, et al. A predictive model for assessing prognostic risks in gastric cancer patients using gene expression and methylation data [J]. BMC Med Genomics, 2021, 14(1): 14. doi: 10.1186/s12920-020-00856-0. [20] Wen J, Zheng T, Hu K, et al. Promoter methylation of tumor-related genes as a potential biomarker using blood samples for gastric cancer detection [J]. Oncotarget, 2017, 8(44): 77783-77793. [21] Skvortsova K, Stirzaker C, Taberlay P. The DNA methylation landscape in cancer [J]. Essays Biochem, 2019, 63(6): 797-811. [22] Morrow JD, Cho MH, Hersh CP, et al. DNA methylation profiling in human lung tissue identifies genes associated with COPD [J]. Epigenetics, 2016, 11(10): 730-739. [23] Pan Y, Liu G, Zhou F, et al. DNA methylation profiles in cancer diagnosis and therapeutics [J]. Clin Exp Med, 2018, 18(1): 1-14. [24] Li T, Chen X, Gu M, et al. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis [J]. Clin Epigenetics, 2020, 12(1): 161. doi: 10.1186/s13148-020-00940-3. [25] Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients [J]. Nat Rev Cancer, 2011, 11(6): 426-437. [26] van der Pol Y, Mouliere F. Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA [J]. Cancer Cell, 2019, 36(4): 350-368. [27] Machlowska J, Baj J, Sitarz M, et al. Gastric Cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies [J]. Int J Mol Sci, 2020, 21(11): 4012. doi: 10.3390/ijms21114012. [28] Lin C, He H, Liu H, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer [J]. Gut, 2019, 68(10): 1764-1773. [29] Parashar S, Cheishvili D, Mahmood N, et al. DNA methylation signatures of breast cancer in peripheral T-cells [J]. BMC Cancer, 2018, 18(1): 574. doi: 10.1186/s12885-018-4482-7. [30] 陈海燕. CA724、CEA、CA242、CA199肿瘤标志物联合检验在胃癌中的诊断价值[J]. 中国医药导报,2012, 9(31): 97-98. Chen HY. CA724、CEA、CA242、CA199 Diagnosis value of CA724, CEA, CA242, CA199 tumor markers for detecting gastric cancer [J]. Medicine Industry Information,2012, 9(31): 97-98. [31] Konishi M, Erdem SS, Weissleder R, et al. Imaging Granzyme B activity assesses immune-mediated myocarditis [J]. Circ Res, 2015, 117(6): 502-512. [32] Wu CH, Li J, Li L, et al. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells [J]. J Extracell Vesicles, 2019, 8(1): 1588538. doi: 10.1080/20013078.2019.1588538. [33] Wu Y, Wan X, Jia G, et al. Aberrantly methylated and expressed genes as prognostic epigenetic biomarkers for colon cancer [J]. DNA Cell Biol, 2020, 39(11): 1961-1969. |
| [1] | WANG Ye, WANG Gang, NAN Haiou, CAI Yuling, LI Jiayu, WANG Haifeng, YAN Yingjie, JIANG Zhiwei. Correlation between perioperative heart rate variability and inflammatory indicators in gastric cancer patients [J]. Journal of Shandong University (Health Sciences), 2026, 64(4): 23-30. |
| [2] | XUE Fuzhong. Theoretical and methodological framework for multimodal big data cohort design based on AI language representation [J]. Journal of Shandong University (Health Sciences), 2025, 63(8): 1-16. |
| [3] | ZHU Yongcai, XIE Yan, QI Qiuchen, LI Peilong, WANG Chuanxin, DU Lutao. Value of a combined model based on ATM gene methylation of peripheral blood mononuclear cells in the early diagnosis of pancreatic cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 78-88. |
| [4] | JIA Ruoxi, LYU Li, LIU Hanyun, WU Yinping, LI Fengcai, ZHAO Zehua, WANG Kai, FAN Yuchen. Diagnostic value of blood cell count-related biomarkers in predicting 28-day mortality in acute-on-chronic hepatitis b liver failure [J]. Journal of Shandong University (Health Sciences), 2025, 63(6): 89-99. |
| [5] | ZHAO Hanqing, ZHOU Xinrui, LI Zijian, TANG Xing. Application of circulating tumor cells combined with serological detection in non-small cell lung cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 79-85. |
| [6] | DU Xue, LI Chunxia, LIU Yunxia, ZHANG Tao. Dynamic prediction model for the colorectal cancer patients prognosis based on MFPC-Cox [J]. Journal of Shandong University (Health Sciences), 2025, 63(5): 101-110. |
| [7] | ZHANG Jie, ZHAO Yinghui, DONG Yaqi, LI Juan, LI Peilong, DU Lutao. Role of GPR133 gene methylation in predicting lymph node metastasis in early gastric cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(3): 76-84. |
| [8] | CHEN Wenliang, WANG Huanhuan, HAO Jinjin, GONG Rui, ZHAO Qiang, ZHANG Fei, GAO Lei, DONG Jingxun. The role of lncRNA PVT1 in prognostic assessment and malignant progression of gastric cancer: a study based on nomogram model and functional cellular experiments [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 61-71. |
| [9] | WANG Jing, LIU Xiaofei, ZENG Rong, XU Changjuan, ZHANG Jintao, DONG Liang. Identification of necroptosis-related biomarkers in asthma based on machine learning algorithms [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 21-32. |
| [10] | GUO Zhenjiang, WANG Ning, ZHAO Guangyuan, DU Liqiang, CUI Zhaobo, LIU Fangzhen. Development of preoperative models for predicting positive esophageal margin in proximal gastric cancer based on machine learning [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 78-83. |
| [11] | SHI Shuochuan, ZENG Rong, ZHANG Jintao, ZHANG Dong, PAN Yun, LIU Xiaofei, XU Changjuan, WANG Ying, DONG Liang. Bioinformatics-based exploration of potential differential immune genes and immune infiltration signatures in bronchial asthma [J]. Journal of Shandong University (Health Sciences), 2024, 62(5): 43-53. |
| [12] | BAI Xiaoliang, SUN Panpan, WANG Hongli, GONG Shunzhi, SUN Yunqi, SHU Meng, QI Xiaoliang. Animal experiment of medical thoracoscopic splanchnotomy [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 9-13. |
| [13] | GUO Xin, MENG Jun, ZHENG Shiliang, DONG Xiuhong. Correlation between frailty and body composition in elderly patients with gastric cancer [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 40-47. |
| [14] | GUO Haonan, ZHOU Peng, LI Xiaolei, YUE Tao, XU Jing, SHAO Changxiu, HE Qingqing, ZHUANG Dayong. Efficacy of total parathyroidectomy and total parathyroidectomy with autotransplantation in treatment of secondary hyperparathyroidism [J]. Journal of Shandong University (Health Sciences), 2024, 62(12): 72-81. |
| [15] | WANG Yutao, SUN Yan. Comprehensive analysis of single-cell transcriptomics and machine learning reveals potential biomarkers for abdominal aortic aneurysm [J]. Journal of Shandong University (Health Sciences), 2024, 62(11): 40-53. |
|
||